Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Pharmacotherapy for Alcohol-Related Disorders: What Clinicians Should Know

Mariani, John J. MD1,†; Levin, Frances R. MD1

doi: 10.1080/10673220490905697
Research Article
Buy

Alcohol-related disorders are a major public health problem in the United States. Alcohol interacts with several neurotransmitter systems causing both acute and chronic effects in the brain. While the mainstay of treatment of alcohol-related disorders, with the exception of alcohol withdrawal, has historically been psychosocial, pharmacotherapy is increasingly being investigated and incorporated into standard clinical practice. Patients with alcohol use disorders and comorbid psychiatric conditions, most commonly depressive and anxiety disorders, can benefit from symptom-targeted pharmacotherapy, even if the patient fails to achieve abstinence from alcohol. Although benzodiazepines remain the treatment of choice to treat alcohol withdrawal, a variety of other agents is being investigated, particularly in the outpatient setting. Further randomized clinical trials of alcohol-related disorder pharmacotherapy, particularly of comorbid subpopulations, are needed to better inform clinical decision making. The routine exclusion of alcohol-dependent patients from pharmacotherapy trials of psychiatric disorders presents a barrier to gathering more data. Recommendations for future research are discussed.

1From Columbia University College of Physicians and Surgeons Department of Psychiatry Division on Substance Abuse.

Supported, in part, by National Institute on Drug Abuse grant nos. T32-DA007294-11 (Dr. Mariani) and K02 00465 (Dr. Levin).

Original manuscript received 13 April 2004; revised manuscript received 24 August 2004, accepted for publication 29 September 2004.

Reprint requests: John J. Mariani, MD, New York State Psychiatric Institute, Division on Substance Abuse, 1051 Riverside Dr., Unit 66, New York, NY 10032. Email: Mariani@pi.cpmc.columbia.edu

© 2004 President and Fellows of Harvard College
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website